You are here

Nicholas Leider
Managing Editor
Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

The Journal of the American College of Cardiologists announced its decision to retract a June study titled, "Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients Results From the Randomized OASIS Trial," because of problems discovered with its being a randomized trial.

Last December, the American Heart Association (AHA) and American College of Cardiologists (ACC) recently release updated guidelines for competitive athletes with cardiovascular abnormalities. The changes have allowed more individuals with conditions to get back on the field, including a soccer star from Rolla, Missouri, who was featured in an article by the St. Louis Dispatch.

 - ecg, heart, electrophysiology

Recent research shows that atrial fibrillation (AF), while more common in white people, is much more dangerous and deadly for black individuals.

 - brain, stroke

Nearly 40% of atrial fibrillation (AF) patients with an intermediate to high risk of stroke are not receiving optimal treatment, according to a June 20 study in the Journal of the American College of Cardiology.

Health insurers are trying to reach deals with drug companies that tie compensation with what they—or, more precisely, their patients—get.